North America
The Parry-Romberg Syndrome market in North America is witnessing gradual growth due to the increasing awareness of the condition and advancements in diagnostic techniques. The United States, with its advanced healthcare infrastructure, leads the market, driven by a growing number of reported cases and a focus on personalized treatment options. Canada is also seeing an uptick in...